Adaptive Biotechnologies (ADPT) Other Non-Current Assets (2018 - 2026)

Adaptive Biotechnologies (ADPT) has 9 years of Other Non-Current Assets data on file, last reported at $2.7 million in Q1 2026.

• Quarterly Other Non-Current Assets changed 0.07% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 million (changed 0.07% YoY) and the FY2025 annual result came in at $1.2 million, down 47.22% from the prior year.
• Other Non-Current Assets rose to $2.7 million in Q1 2026 per ADPT's latest filing, from $1.2 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $3.4 million in Q2 2023, with the low at $874000.0 in Q1 2022.
• Average Other Non-Current Assets over 5 years is $2.5 million, with a median of $2.6 million recorded in 2024.
• The widest YoY moves for Other Non-Current Assets: up 174.06% in 2022, down 58.38% in 2022.
• Adaptive Biotechnologies' Other Non-Current Assets stood at $2.4 million in 2022, then increased by 20.93% to $2.9 million in 2023, then fell by 21.14% to $2.3 million in 2024, then sank by 47.22% to $1.2 million in 2025, then soared by 124.44% to $2.7 million in 2026.
• Business Quant data shows ADPT's Other Non-Current Assets at $2.7 million in Q1 2026, $1.2 million in Q4 2025, and $2.7 million in Q3 2025.